Table of Contents 2012-2023 Global Neurotherapeutic Drugs Market Research Report by Manufacturers, Regions, Types and Applications 1 Neurotherapeutic Drugs Market Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Neurotherapeutic Drugs Segment by Type (Product Category) 1.2.1 Neurotherapeutic Drugs Segment by Types (Product Category) and Its Subclasses 1.2.2 Global Neurotherapeutic Drugs Production Market Share by Type (Product Category) in 2016 1.2.3 Different Subclasses for Peripheral Nervous System Disorders (PNS) Disorder 1.2.3.1 Subclass 1 1.2.3.2 Subclass 2 1.2.3.3 Subclass 3 1.2.4 Different Subclasses for Autonomous Nervous System (ANS) Disorder 1.2.4.1 Subclass 1 1.2.4.2 Subclass 2 1.2.4.3 Subclass 3 1.2.5 Different Subclasses for Central Nervous System (CNS) Disorders 1.2.5.1 Subclass 1 1.2.5.2 Subclass 2 1.2.5.3 Subclass 3 1.3 Global Neurotherapeutic Drugs Segment by Application 1.3.1 Global Neurotherapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 New Project SWOT Analysis of Neurotherapeutic Drugs 1.5 Industry News Analysis of Neurotherapeutic Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of Neurotherapeutic Drugs 3 Global Neurotherapeutic Drugs Manufacturers Profiles/Analysis 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.1.2.2 Autonomous Nervous System (ANS) Disorder 3.1.2.3 Central Nervous System (CNS) Disorders 3.1.3 Abbott Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.2.2.2 Autonomous Nervous System (ANS) Disorder 3.2.2.3 Central Nervous System (CNS) Disorders 3.2.3 BD Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.3.2.2 Autonomous Nervous System (ANS) Disorder 3.3.2.3 Central Nervous System (CNS) Disorders 3.3.3 Novartis AG Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.4.2.2 Autonomous Nervous System (ANS) Disorder 3.4.2.3 Central Nervous System (CNS) Disorders 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.5.2.2 Autonomous Nervous System (ANS) Disorder 3.5.2.3 Central Nervous System (CNS) Disorders 3.5.3 Pfizer Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.6.2.2 Autonomous Nervous System (ANS) Disorder 3.6.2.3 Central Nervous System (CNS) Disorders 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.7.2.2 Autonomous Nervous System (ANS) Disorder 3.7.2.3 Central Nervous System (CNS) Disorders 3.7.3 Biogen Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.8.2.2 Autonomous Nervous System (ANS) Disorder 3.8.2.3 Central Nervous System (CNS) Disorders 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.9.2.2 Autonomous Nervous System (ANS) Disorder 3.9.2.3 Central Nervous System (CNS) Disorders 3.9.3 AstraZeneca Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 AstraZeneca Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.10.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.10.2.2 Autonomous Nervous System (ANS) Disorder 3.10.2.3 Central Nervous System (CNS) Disorders 3.10.3 Merck Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Neurotherapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 Global Neurotherapeutic Drugs Market Competition by Manufacturers 4.1 Global Neurotherapeutic Drugs Capacity, Production and Share by Manufacturers (2012-2017) 4.1.1 Global Neurotherapeutic Drugs Capacity (K Units) and Share (%) by Manufacturers (2012-2017) 4.1.2 Global Neurotherapeutic Drugs Production (K Units) and Share (%) by Manufacturers (2012-2017) 4.2 Global Neurotherapeutic Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Global Neurotherapeutic Drugs Average Price (USD/Unit) by Manufacturers (2012-2017) 4.4 Manufacturers Neurotherapeutic Drugs Manufacturing Base Distribution, Sales Area, Product Types 4.5 Neurotherapeutic Drugs Market Competitive Situation and Trends 4.5.1 Neurotherapeutic Drugs Market Concentration Rate 4.5.2 Neurotherapeutic Drugs Market Share (%) of Top 3 and Top 5 Manufacturers 5 Global Neurotherapeutic Drugs Production by Regions (2012-2017) 5.1 Global Neurotherapeutic Drugs Capacity (K Units) and Market Share (%) by Regions (2012-2017) 5.2 Global Neurotherapeutic Drugs Production (K Units) and Market Share (%) by Regions (2012-2017) 5.3 Global Neurotherapeutic Drugs Revenue and Market Share (%) by Regions (2012-2017) 5.4 Global Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.5 North America Neurotherapeutic Drugs Production (2012-2017) 5.5.1 North America Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.5.2 North America Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.6 Europe Neurotherapeutic Drugs Production (2012-2017) 5.6.1 Europe Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.6.2 Europe Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.7 China Neurotherapeutic Drugs Production (2012-2017) 5.7.1 China Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.7.2 China Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.8 Japan Neurotherapeutic Drugs Production (2012-2017) 5.8.1 Japan Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.8.2 Japan Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.9 Southeast Asia Neurotherapeutic Drugs Production (2012-2017) 5.9.1 Southeast Asia Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.9.2 Southeast Asia Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.10 India Neurotherapeutic Drugs Production (2012-2017) 5.10.1 India Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.10.2 India Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 6 Global Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.1 Global Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.2 North America Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.3 Europe Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.4 China Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.5 Japan Neurotherapeutic Drugs Consumption (K Units) by Regions (2012-2017) 7 Global Neurotherapeutic Drugs Production, Revenue, Price Trend by Types 7.1 Global Neurotherapeutic Drugs Production (K Units) and Market Share (%) by Types (2012-2017) 7.2 Global Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) by Types (2012-2017) 7.3 Global Neurotherapeutic Drugs Price (USD/Unit) by Type (2012-2017) 7.4 Global Neurotherapeutic Drugs Production Growth (%) by Type (2012-2017) 8 Global Market Analysis by Applications 8.1 Global Consumption (K Units) and Market Share (%) by Applications (2012-2017) 8.2 Global Consumption Growth Rate by Applications (2012-2017) 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Global Neurotherapeutic Drugs Market Forecast (2018-2023) 10.1 Global Neurotherapeutic Drugs Capacity, Production, Revenue Forecast (2018-2023) 10.1.1 Global Neurotherapeutic Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) 10.1.2 Global Neurotherapeutic DrugsRevenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 10.1.3 Global Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 10.2 Global Neurotherapeutic Drugs Production (K Units) Forecast by Regions (2018-2023) 10.2.1 North America Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.2 Europe Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.3 China Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.4 Japan Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.5 Southeast Asia Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.6 India Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.3 Global Neurotherapeutic Drugs Consumption (K Units) Forecast by Regions (2018-2023) 10.3.1 North America Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.2 Europe Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.3 China Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.4 Japan Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.5 Southeast Asia Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.6 India Neurotherapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.4 Global Neurotherapeutic Drugs Production, Revenue and Price Forecast by Type (2018-2023) 10.5 Global Neurotherapeutic Drugs Consumption Forecast by Application (2018-2023) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Disclaimer 12.4 Author List

List of Tables and Figures Figure Global Neurotherapeutic Drugs Market Size (Million USD) Status and Outlook 2012-2023 Table Neurotherapeutic Drugs Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Neurotherapeutic Drugs Consumption (K Units) by Application (2017-2023) Figure Picture of Neurotherapeutic Drugs Figure Global Neurotherapeutic Drugs Production Market Share (%) by Types in 2016 Figure Global Neurotherapeutic Drugs Production Market Share (%) by Subclasses of Peripheral Nervous System Disorders (PNS) Disorder in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Neurotherapeutic Drugs Production Market Share (%) by Subclasses of Autonomous Nervous System (ANS) Disorder in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Neurotherapeutic Drugs Production Market Share (%) by Subclasses of Central Nervous System (CNS) Disorders in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Table Global Neurotherapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) Table Global Neurotherapeutic Drugs Consumption (USD/Unit) Market Share (%) by Applications in 2016 Figure Hosptical Examples Figure Drug Stores Examples Figure Other Examples Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/Unit) Figure Global Raw Material B Price Trend (USD/Unit) Figure Global Raw Material C Price Trend (USD/Unit) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Abbott Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in ???Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in and Its Application Share Table BD Basic Information, Manufacturing Base, Sales Area and Its Competitors Table BD Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure BD Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Neurotherapeutic Drugs Volume in and Its Application Share Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Novartis AG Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Johnson & Johnson Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in and Its Application Share Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pfizer Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in and Its Application Share Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Sanofi-Aventis Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Biogen Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in ???Hosptical and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in and Its Application Share Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors Table GlaxoSmithKline Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in ???Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in and Its Application Share Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors Table AstraZeneca Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Neurotherapeutic Drugs Volume in ???Hosptical and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in and Its Application Share Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Merck Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Merck Neurotherapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Merck Neurotherapeutic Drugs Production Market Share (%) (2012-2017) Figure Merck Neurotherapeutic Drugs Revenue Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Neurotherapeutic Drugs Volume in ???Hosptical and Its Application Share Table Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table Merck Neurotherapeutic Drugs Volume in and Its Application Share Table Global Neurotherapeutic Drugs Capacity (K Units) of Key Manufacturers (2012-2017) Table Global Neurotherapeutic Drugs Capacity Market Share (%) of Key Manufacturers (2012-2017) Figure Global Neurotherapeutic Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Figure Global Neurotherapeutic Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Table Global Neurotherapeutic Drugs Production (K Units) of Key Manufacturers (2012-2017) Table Global Neurotherapeutic Drugs Production Share (%) by Manufacturers (2012-2017) Figure 2016 Neurotherapeutic Drugs Production Share (%) by Manufacturers Figure 2016 Neurotherapeutic Drugs Production Share (%) by Manufacturers Table Global Neurotherapeutic Drugs Revenue (Million USD) by Manufacturers (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share (%) by Manufacturers (2012-2017) Table 2016 Global Neurotherapeutic Drugs Revenue Share (%) by Manufacturers Table 2016 Global Neurotherapeutic Drugs Revenue Share (%) by Manufacturers Table Global Market Neurotherapeutic Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017) Figure Global Market Neurotherapeutic Drugs Average Price (USD/Unit) of Key Manufacturers in 2017 Table Manufacturers Neurotherapeutic Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Neurotherapeutic Drugs Product Category Figure Neurotherapeutic Drugs Market Share (%) of Top 3 Manufacturers Figure Neurotherapeutic Drugs Market Share (%) of Top 5 Manufacturers Table Global Neurotherapeutic Drugs Capacity (K Units) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Capacity Market Share (%) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Capacity Market Share (%) by Regions (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Capacity Market Share (%) by Regions Table Global Neurotherapeutic Drugs Production (K Units) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Production Market Share (%) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Production Market Share (%) by Regions (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Production Market Share (%) by Regions Table Global Neurotherapeutic Drugs Revenue (Million USD) by Regions (2012-2017) Table Global Neurotherapeutic Drugs Revenue Market Share (%) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Revenue Market Share (%) by Regions Figure Global Neurotherapeutic Drugs Capacity, Production (K Units) and Growth Rate (2012-2017) Table Global Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure North America Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table North America Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Europe Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Europe Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure China Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table China Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Japan Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Japan Neurotherapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Table Global Neurotherapeutic Drugs Consumption (K Units) Market by Regions (2012-2017) Table Global Neurotherapeutic Drugs Consumption Market Share (%) by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Consumption Market Share (%) by Regions (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Consumption Market Share (%) by Regions Figure North America Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Europe Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure China Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Japan Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure India Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure South America Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Middle East Neurotherapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Table Global Neurotherapeutic Drugs Production (K Units) by Types (2012-2017) Table Global Neurotherapeutic Drugs Production Share (%) by Types (2012-2017) Figure Production Market Share (%) of Neurotherapeutic Drugs by Types (2012-2017) Figure 2016 Production Market Share (%) of Neurotherapeutic Drugs by Types Table Global Neurotherapeutic Drugs Revenue (Million USD) by Types (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share (%) by Types (2012-2017) Figure Revenue Share (%) of Neurotherapeutic Drugs by Types (2012-2017) Figure 2016 Revenue Market Share (%) of Neurotherapeutic Drugs by Types Table Global Neurotherapeutic Drugs Price (USD/Unit) by Types (2012-2017) Figure Global Neurotherapeutic Drugs Production Growth (%) by Type (2012-2017) Table Global Neurotherapeutic Drugs Consumption (K Units) by Applications (2012-2017) Table Global Neurotherapeutic Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global Neurotherapeutic Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global Neurotherapeutic Drugs Consumption Market Share (%) by Applications in 2017 Table Global Neurotherapeutic Drugs Consumption Growth Rate by Applications (2012-2017) Figure Global Neurotherapeutic Drugs Consumption Growth Rate by Applications (2012-2017) Table Distributors/Traders List Figure Global Neurotherapeutic Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Global Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Global Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) Table Global Neurotherapeutic Drugs Production (K Units) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Production Market Share (%) Forecast by Regions (2018-2023) Figure North America Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Global Neurotherapeutic Drugs Consumption (K Units) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Consumption Market Share (%) Forecast by Regions (2018-2023) Figure North America Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South America Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Middle East Neurotherapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Table Global Neurotherapeutic Drugs Production (K Units) Forecast by Type (2018-2023) Figure Global Neurotherapeutic Drugs Production Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Consumption (K Units) Forecast by Application (2018-2023) Figure Global Neurotherapeutic Drugs Consumption Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck